SER (Serina Therapeutics, Inc.) Stock Analysis - Hedge Fund Holdings

Serina Therapeutics, Inc. (SER) is a publicly traded Healthcare sector company. As of May 21, 2026, SER trades at $1.71 with a market cap of $22.65M and a P/E ratio of -0.90. SER moved +5.59% today. Year to date, SER is -18.27%; over the trailing twelve months it is -70.23%. Its 52-week range spans $1.22 to $8.14. Analyst consensus is buy with an average price target of $11.00. Rallies surfaces SER's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

Who owns SER stock?

Rallies tracks hedge fund and 13F ownership for SER, including fund holders, share counts, and position changes when data is available.

SER Key Metrics

Key financial metrics for SER
MetricValue
Price$1.71
Market Cap$22.65M
P/E Ratio-0.90
EPS$-1.91
Dividend Yield0.00%
52-Week High$8.14
52-Week Low$1.22
Volume91
Avg Volume0
Revenue (TTM)$130.00K
Net Income$-19.21M
Gross Margin0.00%

Latest SER News

Recent SER Insider Trades

  • Moreadith Randall sold 6.50K (~$18.57K) on Mar 23, 2026.
  • Moreadith Randall sold 39.00K (~$97.50K) on Mar 19, 2026.
  • Moreadith Randall sold 6.50K (~$19.68K) on Feb 2, 2026.

SER Analyst Consensus

1 analysts cover SER: 0 strong buy, 1 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is buy. Average price target: $11.00.

Common questions about SER

Who owns SER stock?
Rallies tracks hedge fund and 13F ownership for SER, including fund holders, share counts, and position changes when data is available.
Does Rallies show 13F holders for SER?
Yes. Rallies tracks hedge fund and 13F ownership data for SER, including fund names, share counts, latest tracked quarter, and position changes when available.
Is SER research on Rallies investment advice?
No. Rallies provides research, data, and educational context for SER. It does not provide personalized investment advice.
SER

SER